Fed bans ex-Goldman managing director over supervisory info misuse
By 
Kyle Brasseur2022-04-08T13:25:00
The Federal Reserve Board permanently barred from the banking industry former Goldman Sachs Managing Director Joseph Jiampietro after he allegedly misused confidential supervisory information to further his regulatory advisory practice.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefProbe into Goldman Sachs’ credit card practices expands
Goldman Sachs Group disclosed more regulators—beyond the Consumer Financial Protection Bureau—are investigating its credit card account management practices.
-
Blog
Fed hits Goldman Sachs over use of supervisory information
The Federal Reserve Board has ordered Goldman Sachs Group to pay a $36.3 million civil penalty for the unauthorized use and disclosure of confidential supervisory information in presentations to clients and prospective clients. Joe Mont reports.
-
OpinionWhen AI Is Forced on Compliance: The ECCP as your Guide
When a company rapidly adopts AI, compliance officers can be blindsided, tasked with governance almost immediately. Luckily, there is a guide from the U.S. Department of Justice to help.
More from Regulatory Enforcement
-
ArticleFrench investigators target anticompetitive practices in largest accounting firms
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
-
ArticleEU investigation into Grok may expose problems with DSA rather than compliance failings
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
-
ArticleFormer ADM execs inflated operating profits, SEC alleges
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.